BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/21/2020 12:21:52 PM | Browse: 573 | Download: 789
 |
Received |
|
2020-10-14 07:36 |
|
Peer-Review Started |
|
2020-10-14 07:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-01 17:41 |
|
Revised |
|
2020-12-06 13:23 |
|
Second Decision |
|
2020-12-10 12:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-12-10 20:16 |
|
Articles in Press |
|
2020-12-10 20:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-12-18 10:35 |
|
Publish the Manuscript Online |
|
2020-12-21 12:21 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Review |
| Article Title |
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tsinrong Lee, Thomas Zheng Jie Teng and Vishal G Shelat |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tsinrong Lee, N/A, N/A, Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Singapore 308232, Singapore. leet0043@e.ntu.edu.sg |
| Key Words |
Carbohydrate antigen 19-9 antigen; Pancreatic diseases; Liver diseases; Biliary tract diseases; Gastrointestinal diseases; Pancreatic neoplasms |
| Core Tip |
Carbohydrate antigen 19-9 (CA 19-9) is the “go-to” tumor marker when one discusses the diagnosis, prognosis, and recurrence of pancreatic ductal adenocarcinoma. However, its utility in screening special population groups and determining management for pancreatic ductal adenocarcinoma is more obscure, with many interpretations of its utility in the literature. Additionally, CA 19-9 is useful beyond pancreatic pathologies, with current studies pointing towards its potential use in gastrointestinal, urological, pulmonary, uterine, ovarian, thyroid, and salivary gland diseases. We provide an in-depth analysis of the current practices of CA 19-9 and its potential applications in the future. |
| Publish Date |
2020-12-21 12:21 |
| Citation |
Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World J Gastrointest Surg 2020; 12(12): 468-490 |
| URL |
https://www.wjgnet.com/1948-9366/full/v12/i12/468.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v12.i12.468 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
